Adequacy of Inclusion of Older Adults in NIH‐Funded Phase III Clinical Trials

In the United States, the population aged 65 and older is rapidly growing, and this group uses more healthcare resources and has unique healthcare needs that do not exist in younger populations. However, it was reported that older adults are excluded or underrepresented in clinical trials for severa...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Journal of the American Geriatrics Society (JAGS) Ročník 67; číslo 2; s. 218 - 222
Hlavní autoři:	Lockett, Jaron, Sauma, Samir, Radziszewska, Barbara, Bernard, Marie A.
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	Hoboken, USA John Wiley & Sons, Inc 01.02.2019 Wiley Subscription Services, Inc
Témata:	Adults Age Factors Aged Aged, 80 and over Arteriosclerosis Atherosclerosis Cancer Chronic obstructive pulmonary disease Clinical research Clinical trials Clinical Trials, Phase III as Topic - economics Clinical Trials, Phase III as Topic - statistics & numerical data Comorbidity Congestive heart failure Disease exclusion Female Health care Health services Heart failure Hospitalization Humans inclusion in clinical trials Institutes Lung cancer Lung diseases Male Myocardial infarction National Institutes of Health (U.S.) - economics Obstructive lung disease Older people Osteoarthritis Patient Selection Pneumonia Prescription drugs Prostate Prostate cancer Research Subjects - statistics & numerical data Research Support as Topic Stroke trials United States United States trials exclusion inclusion in clinical trials
ISSN:	0002-8614, 1532-5415, 1532-5415
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!